TORONTO, ONTARIO--(Marketwire - June 02, 2008) - PharmEng International Inc. (TSX VENTURE: PII), a full-service consulting and contract manufacturing company, today reported its results for the period ended December 31, 2007. The Company has demonstrated continued strong revenue growth of 18% during 2007 over the previous year and continues to execute on its strategic plan. While this continued revenue growth in 2007 is offset by 2007 losses, management is focused on bringing the Company to profitability in 2008.
